MedWatch

Danish notified body expected approved in 2023

More than a year will pass before Denmark will once again have a notified body for the approval of medtech products. Industry association Medicoindustrien warns of a ”huge capacity crisis,” which will only grow – particularly affecting one part of the industry.

German Tüv Süd continues to be the only applicant to become a notified body in Denmark

BRUSSELS – Although the medtech industry warns of a greater ”capacity crisis,” the sector shouldn’t be expecting to have products approved locally in Denmark for sale in the EU any time soon.

This message comes from one of the central players in the extensive approval process, the Danish Medicines Agency. The authority tells MedWatch that the case processing of an application from German Tüv Süd to become a notified body in Denmark isn’t anticipated to be concluded before summer 2023.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Sanofi reduces US insulin prices for the uninsured

While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.

Further reading

Related articles

Latest news

See all jobs